Study of clofutriben in people with kidney impairment
Part of Kidney & urinary clinical trials.
This study tests how the drug clofutriben is processed in people with moderate kidney impairment compared to those with normal kidneys. It helps determine if dose adjustments are needed in kidney patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your kidney function (eGFR) must be either moderately impaired (30-60) or normal (90 or higher).
- You must not have any other serious medical conditions that could make the study risky.
- Your recent heart test (ECG), vital signs, and lab results must be normal or not clinically significant.
- You must be matched by sex, age, and weight to a control participant with normal kidney function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how different levels of kidney function affect the levels of a new investigational drug called Ribupatide in the blood. It helps doctors understand how the drug works in people with various kidney conditions.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests an experimental drug called INCB161734 in people with severe kidney disease or those on dialysis. It aims to see how the drug behaves in the body and if it is safe.
This trial tests how a new drug called ammoxetine works in people with moderate kidney impairment compared to those with normal kidney function. It aims to find the right dose and understand how the drug is processed by the body.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
Hear when a new Moderate Renal Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.